National Bank of Canada’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.56M | Buy |
+493,900
| New | +$5.56M | 0.01% | 755 |
|
2025
Q1 | – | Sell |
-305
| Closed | -$3K | – | 2558 |
|
2024
Q4 | $3K | Sell |
305
-780
| -72% | -$7.66K | ﹤0.01% | 2148 |
|
2024
Q3 | $8.84K | Buy |
1,085
+126
| +13% | +$1.03K | ﹤0.01% | 1923 |
|
2024
Q2 | $12.4K | Hold |
959
| – | – | ﹤0.01% | 1931 |
|
2024
Q1 | $29.2K | Buy |
959
+192
| +25% | +$5.84K | ﹤0.01% | 1734 |
|
2023
Q4 | $50.9K | Buy |
767
+450
| +142% | +$29.9K | ﹤0.01% | 1593 |
|
2023
Q3 | $21.7K | Sell |
317
-125
| -28% | -$8.54K | ﹤0.01% | 1803 |
|
2023
Q2 | $32.7K | Buy |
442
+19
| +4% | +$1.4K | ﹤0.01% | 1731 |
|
2023
Q1 | $22.4K | Sell |
423
-2,393
| -85% | -$126K | ﹤0.01% | 1799 |
|
2022
Q4 | $190K | Buy |
2,816
+161
| +6% | +$10.9K | ﹤0.01% | 1345 |
|
2022
Q3 | $331K | Buy |
2,655
+1,889
| +247% | +$236K | ﹤0.01% | 1105 |
|
2022
Q2 | $73K | Sell |
766
-3,097
| -80% | -$295K | ﹤0.01% | 1459 |
|
2022
Q1 | $623K | Buy |
3,863
+3,850
| +29,615% | +$621K | ﹤0.01% | 1069 |
|
2021
Q4 | $4K | Buy |
+13
| New | +$4K | ﹤0.01% | 2335 |
|